Modulation of intestinal permeability of 5-fluorouracil via phospholipid interaction based lipophilic complex designing and pharmacokinetic assessment

References

• Sri, R. M.; Sangeetha, S.; Seetha, D. A. Solid Lipid Nanoparticles: A Potential Option for Enhancing Oral Bioavailability of Highly Soluble and Poorly Permeable (BCS Class III) Drugs. Curr. Drug Del. 2023, 20, 223–236. DOI: 10.2174/1567201819666220418100410.
   PubMed Web of Science ®Google Scholar
• Asad, M.; Rasul, A.; Abbas, G.; Shah, M. A.; Nazir, I. Self-Emulsifying Drug Delivery Systems: A Versatile Approach to Enhance the Oral Delivery of BCS Class III Drug via Hydrophobic Ion Pairing. PLoS One. 2023, 18, e0286668. DOI: 10.1371/journal.pone.0286668.
   PubMed Web of Science ®Google Scholar
• Jindal, A.; Kumar, A. Physical Characterization of Clove Oil Based Self Nano-Emulsifying Formulations of Cefpodoxime Proxetil: Assessment of Dissolution Rate, Antioxidant & Antibacterial Activity. OpenNano 2022, 8, 100087. DOI: 10.1016/j.onano.2022.100087.
   Google Scholar
• Tsume, Y.; Amidon, G. L. The Biowaiver Extension for BCS Class III Drugs: The Effect of Dissolution Rate on the Bioequivalence of BCS Class III Immediate-Release Drugs Predicted by Computer Simulation. Mol. Pharm. 2010, 7, 1235–1243. DOI: 10.1021/mp100053q.
   PubMed Web of Science ®Google Scholar
• Gnananath, K.; Nataraj, K. S.; Rao, B. G. Phospholipid Complex Technique for Superior Bioavailability of Phytoconstituents. Adv. Pharm. Bull. 2017, 7, 35–42. DOI: 10.15171/apb.2017.005.
   PubMed Web of Science ®Google Scholar
• Bhalani, D. V.; Nutan, B.; Kumar, A.; Singh, C. A. K. Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics. Biomedicines 2022, 10, 2055. DOI: 10.3390/biomedicines10092055.
   PubMed Web of Science ®Google Scholar
• Chang-Can, S. H.; Kun-Ming, Q. I.; Xu, K.; An, C. H.; Ting, C. A.; Bao-Chang, C. A. Development of Liquiritigenin-Phospholipid Complex with the Enhanced Oral Bioavailability. Chin. J. Nat. Med. 2020, 18, 916–921. DOI: 10.1016/S1875-5364(20)60035-8.
   PubMed Web of Science ®Google Scholar
• Singh, C.; Bhatt, T. D.; Gill, M. S.; Suresh, S. Novel Rifampicin–Phospholipid Complex for Tubercular Therapy: Synthesis, Physicochemical Characterization and in-Vivo Evaluation. Int. J. Pharm. 2014, 460, 220–227. DOI: 10.1016/j.ijpharm.2013.10.043.
   PubMed Web of Science ®Google Scholar
• Tan, Q.; Liu, S.; Chen, X.; Wu, M.; Wang, H.; Yin, H.; He, D.; Xiong, H.; Zhang, J. Design and Evaluation of a Novel Evodiamine-Phospholipid Complex for Improved Oral Bioavailability. AapsPharmsci 2012, 13, 534–547. DOI: 10.1208/s12249-012-9772-9.
   Google Scholar
• Tedesco, D.; Steidler, S.; Galletti, S.; Tameni, M.; Sonzogni, O.; Ravarotto, L. Efficacy of Silymarin-Phospholipid Complex in Reducing the Toxicity of Aflatoxin B1 in Broiler Chicks. Poult. Sci. 2004, 83, 1839–1843. DOI: 10.1093/ps/83.11.1839.
   PubMed Web of Science ®Google Scholar
• Yue, P. F.; Yuan, H. L.; Li, X. Y.; Yang, M.; Zhu, W. F. Process Optimization, Characterization and Evaluation in Vivo of Oxymatrine–Phospholipid Complex. Int. J. Pharm. 2010, 387, 139–146. DOI: 10.1016/j.ijpharm.2009.12.008.
   PubMed Web of Science ®Google Scholar
• Jena, S. K.; Singh, C.; Dora, C. P.; Suresh, S. Development of Tamoxifen-Phospholipid Complex: Novel Approach for Improving Solubility and Bioavailability. Int. J. Pharm. 2014, 473, 1–9. DOI: 10.1016/j.ijpharm.2014.06.056.
   PubMed Web of Science ®Google Scholar
• Semalty, A.; Semalty, M.; Singh, D.; Rawat, M. S. Development and Characterization of Aspirin-Phospholipid Complex for Improved Drug Delivery. PCI- Approved-IJPSN. 2010, 3, 940–947. DOI: 10.37285/ijpsn.2010.3.2.7.
   Google Scholar
• Diasio, R. B.; Harris, B. E. Clinical Pharmacology of 5-Fluorouracil. Clin. Pharmacokinet. 1989, 16, 215–237. DOI: 10.2165/00003088-198916040-00002.
   PubMed Web of Science ®Google Scholar
• Rider, B. J. xPharm: The Comprehensive Pharmacology Reference. ǁ 5 Fluorouracil 2007, 1–5. DOI: 10.1016/b978-008055232-3.61123-7.
   Google Scholar
• Gautam, M. K.; Besan, M.; Pandit, D.; Mandal, S.; Chadha, R. Cocrystal of 5-Fluorouracil: Characterization and Evaluation of Biopharmaceutical Parameters. AAPS PharmSci 2019, 20, 1–7.
   Web of Science ®Google Scholar
• Pangeni, R.; Choi, S. W.; Jeon, O. C.; Byun, Y.; Park, J. W. Multiple Nanoemulsion System for an Oral Combinational Delivery of Oxaliplatin and 5-Fluorouracil: Preparation and in Vivo Evaluation. Int. J. Nanomedicine. 2016, 11, 6379–6399. DOI: 10.2147/IJN.S121114.
   PubMed Web of Science ®Google Scholar
• Sun, Y.; Zhao, D.; Wang, G.; Jiang, Q.; Guo, M.; Kan, Q.; He, Z.; Sun, J. A Novel Oral Prodrug-Targeting Transporter MCT 1: 5-Fluorouracil-Dicarboxylate Monoester Conjugates. Asian J. Pharm. Sci. 2019, 14, 631–639. DOI: 10.1016/j.ajps.2019.04.001.
   PubMed Web of Science ®Google Scholar
• Maheshwari, M. Development and Evaluation of Novel Microemulsion Based Oral Formulations of 5-Fluorouracil Using Non-Everted Rat Intestine Sac Model. Drug Dev Ind Pharm. 2012, 38(3), 294–300. DOI: 10.3109/03639045.2011.602407.
   PubMed Web of Science ®Google Scholar
• Yu, Y. M.; Niu, Y. Y.; Wang, L. Y.; Li, Y. T.; Wu, Z. Y.; Yan, C. W. Supramolecular Self-Assembly and Perfected in Vitro/Vivo Property of 5-Fluorouracil and Ferulic Acid on the Strength of Double Optimized Strategy: The First 5-Fluorouracial-Phenolic Acid Nutraceutical Cocrystal with Synergistic Antitumor Efficacy. Analyst 2021, 146, 2506–2519. DOI: 10.1039/d1an00171j.
   PubMed Web of Science ®Google Scholar
• Zou, W.; Sun, W.; Zhang, N.; Xu, W. Enhanced Oral Bioavailability and Absorption Mechanism Study of N3-O-Toluyl-Fluorouracil-Loaded Liposomes. J. Biomed. Nanotech. 2008, 1, 90–98. DOI: 10.1166/jbn.2008.005.
   Google Scholar
• Ahmad, N.; Albassam, A. A.; Khan, M. F.; Ullah, Z.; Buheazah, T. M.; AlHomoud, H. S.; Al-Nasif, H. A. A Novel 5-Fluorocuracil Multiple-Nanoemulsion Used for the Enhancement of Oral Bioavailability in the Treatment of Colorectal Cancer. Saudi J. Biol. Sci. 2022, 29, 3704–3716. DOI: 10.1016/j.sjbs.2022.02.017.
   PubMed Web of Science ®Google Scholar
• Wielińska, J.; Nowacki, A.; Liberek, B. 5-Fluorouracil-Complete Insight into Its Neutral and Ionised Forms. Molecules 2019, 24, 3683. DOI: 10.3390/molecules24203683.
   PubMed Web of Science ®Google Scholar
• Singh, D.; Rawat, M. S.; Semalty, A.; Semalty, M. Quercetin-Phospholipid Complex: An Amorphous Pharmaceutical System in Herbal Drug Delivery. Curr. Drug Discov. Technol. 2012, 9, 17–24. DOI: 10.2174/157016312799304507.
   PubMedGoogle Scholar
• Pathan Rahila, A.; Bhandari, U. Preparation & Characterization of Embelin–Phospholipid Complex as Effective Drug Delivery Tool. J. Incl. Phenom. Macrocycl. Chem. 2011, 69, 139–147. DOI: 10.1007/s10847-010-9824-2.
   Web of Science ®Google Scholar
• Jangir, D. K.; Charak, S.; Mehrotra, R.; Kundu, S. FTIR and Circular Dichroism Spectroscopic Study of Interaction of 5-Fluorouracil with DNA. J. Photochem. Photobiol. B 2011, 105, 143–148. DOI: 10.1016/j.jphotobiol.2011.08.003.
   PubMed Web of Science ®Google Scholar
• Nawaz, A.; Ullah, S.; Alnuwaiser, M. A.; Rehman, F. U.; Selim, S.; Al Jaouni, S. K.; Farid, A. Formulation and Evaluation of Chitosan-Gelatin Thermosensitive Hydrogels Containing 5fu-Alginate Nanoparticles for Skin Delivery. Gels 2022, 8, 537. DOI: 10.3390/gels8090537.
   PubMed Web of Science ®Google Scholar
• Lenz, H.; Niedzwiecki, D.; Innocenti, F.; Blanke, C.; Mahony, M. R.; O'Neil, B. H.; Shaw, J. E.; Polite, B.; Hochster, H.; Atkins, J.; et al. CALGB/SWOG 80405: Phase III Trial of Irinotecan/5-FU/Leucovorin (FOLFIRI) or Oxaliplatin/5-FU/Leucovorin (mFOLFOX6) with Bevacizumab (BV) or Cetuximab (CET) for Patients (Pts) with Expanded Ras Analyses Untreated Metastatic Adenocarcinoma of the Colon or Rectum (mCRC). Ann. Oncol. 2014, 25, v1. DOI: 10.1093/annonc/mdu438.13.
   Google Scholar
• Moisescu-Goia, C.; Muresan-Pop, M.; Simon, V. New Solid State Forms of Antineoplastic 5-Fluorouracil with Anthelmintic Piperazine. J. of Mol. Stru 2017, 1150, 37–43. DOI: 10.1016/j.molstruc.2017.08.076.
   Web of Science ®Google Scholar
• Sastre, R. L.; Blanco, M. D.; Teijón, C.; Olmo, R.; Teijón, J. M. Preparation and Characterization of 5‐Fluorouracil‐Loaded Poly (ϵ‐Caprolactone) Microspheres for Drug Administration. Drug Dev. Res. 2004, 63, 41–53. DOI: 10.1002/ddr.10396.
   Web of Science ®Google Scholar
• Torchilin, V. P.; Weissig, V. editors. Liposomes: A Practical Approach; Oxford Uni. Press. 2003.
   Google Scholar
• Jin, L.; Liu, Q.; Sun, Z.; Ni, X.; Wei, M. Preparation of 5-Fluorouracil/β-Cyclodextrin Complex Intercalated in Layered Double Hydroxide and the Controlled Drug Release Properties. Ind. Eng. Chem. Res. 2010, 49, 11176–11181. DOI: 10.1021/ie100990z.
   Web of Science ®Google Scholar
• Oktay, S.; Alemdar, N. Electrically Controlled Release of 5-Fluorouracil from Conductive Gelatin Methacryloyl‐Based Hydrogels. J. of Applied Polymer Sci. 2019, 136, 46914. DOI: 10.1002/app.46914.
   Web of Science ®Google Scholar
• Avachat, A. M.; Patel, V. G. Self Nanoemulsifying Drug Delivery System of Stabilized Ellagic Acid–Phospholipid Complex with Improved Dissolution and Permeability. Saudi Pharm. J. 2015, 23, 276–289. DOI: 10.1016/j.jsps.2014.11.001.
   PubMed Web of Science ®Google Scholar
• Maring, J. G.; Schouten, L.; Greijdanus, B.; de Vries, E. G.; Uges, D. R. A Simple and Sensitive Fully Validated HPLC-UV Method for the Determination of 5-Fluorouracil and Its Metabolite 5, 6-Dihydrofluorouracil in Plasma. Ther. Drug Monit. 2005, 27, 25–30. DOI: 10.1097/00007691-200502000-00006.
   PubMed Web of Science ®Google Scholar
• Mutalik, S.; Shetty, P. K.; Kumar, A.; Kalra, R.; Parekh, H. S. Enhancement in Deposition and Permeation of 5-Fluorouracil through Human Epidermis Assisted by Peptide Dendrimers. Drug Deliv. 2014, 21, 44–54. DOI: 10.3109/10717544.2013.845861.
   PubMed Web of Science ®Google Scholar
• Ai, F.; Ma, Y.; Wang, J.; Li, Y. Preparation, Physicochemical Characterization and in-Vitro Dissolution Studies of Diosmin-Cyclodextrin Inclusion Complexes. Iranian J. of Pharm. Res 2014, 13, 1115.
   PubMed Web of Science ®Google Scholar
• Tummala, S.; Kumar, M. S.; Prakash, A. Formulation and Characterization of 5-Fluorouracil Enteric Coated Nanoparticles for Sustained and Localized Release in Treating Colorectal Cancer. Saudi Pharm. J. 2015, 23, 308–314. DOI: 10.1016/j.jsps.2014.11.010.
   PubMed Web of Science ®Google Scholar
• Zhuo, R. X.; Du, B.; Lu, Z. R. In Vitro Release of 5-Fluorouracil with Cyclic Core Dendritic Polymer. J. Control. Release 1999, 57, 249–257. DOI: 10.1016/S0168-3659(98)00120-5.
   PubMed Web of Science ®Google Scholar
• Xia, H. J.; Zhang, Z. H.; Jin, X.; Hu, Q.; Chen, X. Y.; Jia, X. B. A Novel Drug–Phospholipid Complex Enriched with Micelles: Preparation and Evaluation in Vitro and in Vivo. Int. J. Nanomedicine. 2013, 8, 545–554. DOI: 10.2147/IJN.S39526.
   PubMed Web of Science ®Google Scholar
• Alagili, M. F.; AlQuadeib, B. T.; Ashri, L. Y.; Ibrahim, M. A. Optimization and Evaluation of Lisinopril Mucoadhesive Sustained Release Matrix Pellets: In-Vitro and Ex-Vivo Studies. Saudi Pharm. J. 2023, 31, 101690. DOI: 10.1016/j.jsps.2023.06.023.
   PubMed Web of Science ®Google Scholar
• Cui, F.; Shi, K.; Zhang, L.; Tao, A.; Kawashima, Y. Biodegradable Nanoparticles Loaded with Insulin–Phospholipid Complex for Oral Delivery: Preparation, in Vitro Characterization and in Vivo Evaluation. J. Control. Release 2006, 114, 242–250. DOI: 10.1016/j.jconrel.2006.05.013.
   PubMed Web of Science ®Google Scholar
• Maiti, K.; Mukherjee, K.; Gantait, A.; Saha, B. P.; Mukherjee, P. K. Curcumin–Phospholipid Complex: Preparation, Therapeutic Evaluation and Pharmacokinetic Study in Rats. Int. J. Pharm. 2007, 330, 155–163. DOI: 10.1016/j.ijpharm.2006.09.025.
   PubMed Web of Science ®Google Scholar
• Semalty, A.; Semalty, M.; Singh, D.; Rawat, M. S. Preparation and Characterization of Phospholipid Complexes of Naringenin for Effective Drug Delivery. J. Incl. Phenom. Macrocycl. Chem. 2010, 67, 253–260. DOI: 10.1007/s10847-009-9705-8.
   Web of Science ®Google Scholar
• Gustavsson, T.; Sarkar, N.; Bányász, Á.; Markovitsi, D.; Improta, R. Solvent Effects on the Steady‐State Absorption and Fluorescence Spectra of Uracil, Thymine and 5-Fluorouracil. Photochem. Photobiol. 2007, 83, 595–599. DOI: 10.1111/j.1751-1097.2007.00052.x.
   PubMed Web of Science ®Google Scholar
• Yu, Y. M.; Liu, L.; Bu, F. Z.; Li, Y. T.; Yan, C. W.; Wu, Z. Y. A Novice Cocrystal Nanomicelle Formulation of 5-Fluorouracil with Proline: The Design, Self-Assembly and in Vitro/Vivo Biopharmaceutical Characteristics. Int. J. Pharm. 2022, 617, 121635. DOI: 10.1016/j.ijpharm.2022.121635.
   PubMedGoogle Scholar
• Kumar, A.; Jindal, A.; Singh, A. P. K. Cytotoxicity and Bioavailability Assessment from Thiamin-Phospholipid Complexation Loaded Ajwain Oil Based Self Nanoemulsifying System. J. of Dispersion Sci. and Tech 2023, 4, 1–17. DOI: 10.1080/01932691.2023.2266010.
   Google Scholar